Financials data is unavailable for this security.
View more
Year on year Kiora Pharmaceuticals Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 13.58m to a smaller loss of 12.51m.
Gross margin | -- |
---|---|
Net profit margin | 19.98% |
Operating margin | 16.48% |
Return on assets | 10.54% |
---|---|
Return on equity | 11.42% |
Return on investment | 11.20% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Kiora Pharmaceuticals Inc fell by 3.55m. Cash Flow from Financing totalled 5.97m or -- of revenues. In addition the company used 9.56m for operations while cash from investing was breakeven.
Cash flow per share | 1.11 |
---|---|
Price/Cash flow per share | 4.03 |
Book value per share | 11.14 |
---|---|
Tangible book value per share | 8.18 |
More ▼
Balance sheet in USDView more
Current ratio | 19.22 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼